Volume 4, Issue 4 (12-2020)                   EBHPME 2020, 4(4): 217-224 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Amiri S, Mirahmadizadeh A, Seyfi S. The Expense of Insulin in Individuals with Insulin-Dependent Diabetes in Fars Province based on Prescribed Prescriptions including Insulin. EBHPME. 2020; 4 (4) :217-224
URL: http://jebhpme.ssu.ac.ir/article-1-303-en.html
Epidemiology Department, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract:   (99 Views)
Background: Diabetes is considered one of the most prevalent chronic diseases in the world, and if it is not cured, it can have many side effects and expenses. The current study has been conducted to calculate the cost of insulin applied in patients with insulin-dependent diabetes who are younger than 19 years old in 2016 and 2017.
Methods: The current study is a descriptive and cross-sectional study
We investigated all registered prescriptions of social security and health insurance in this study. The price of each insulin was calculated through the official website of the Food and Drug Administration (FDA). Ultimately, the cost of insulin has been calculated based on gender, age group, and insurance types under the age of 19 in patients with insulin-dependent diabetes and those without insulin-dependent diabetes. Data has been analyzed using SPSS24. The frequency command is used to obtain the percentages.
Results: In this study, 1135105 insured cases younger than 19 years old were investigated, which females consisted almost half of the insured cases (51 %), and most of them were in the age group of 2-7 years (34 %), and 50 % of the participants in this study were covered by social security insurance. The treatment of each patient with insulin-dependent diabetes included a cost of $ 1187 and $ 1309, respectively, in 2016 and 2017, and $ 1.4 and $ 1.7 respectively (1$ = 42,000 Rials), for each person under the age of 19 in the general population.
Conclusion: The results achieved by the mentioned study explained that nearly remarkable cost is spent on preparing insulin for patients with Type 1 Diabetes Mellitus every year. This amount is increasing, and it is essential to predict insulin needs for the future according to the insulin consumption changes.
Full-Text [PDF 1534 kb]   (33 Downloads) |   |   Full-Text (HTML)  (40 Views)  
Type of Study: Original article | Subject: Health Economics
Received: 2020/07/26 | Accepted: 2020/12/20 | Published: 2020/12/20

References
1. Tao B, Pietropaolo M, Atkinson M, Schatz D, Taylor D. Estimating the cost of type 1 diabetes in the US: a propensity score matching method. PLoS One. 2010; 5(7): e11501. [DOI:10.1371/journal.pone.0011501]
2. Razavi Z, Karimpourian A, Aramian LM, Bazmamoun H. Demographic Characteristics of Type 1 Diabetic Children and Adolescents in Hamadan, Iran. Journal of Research in Health Sciences. 2015; 15(3): 196-9.
3. Control CfD, Prevention. National diabetes fact sheet. Available from URL: http://www.cdc gov/ diabetes/ pubs/ pdf/ ndfs_2011 pdf. 2011.
4. Control D, Group CTR. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993; 329(14): 977-86. [DOI:10.1056/NEJM199309303291401]
5. Group DP. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabetic Medicine. 2006; 23(8): 857-66. [DOI:10.1111/j.1464-5491.2006.01925.x]
6. Tuomilehto J. The emerging global epidemic of type 1 diabetes. Current Diabetes Reports. 2013; 13(6): 795-804. [DOI:10.1007/s11892-013-0433-5]
7. Laing SP, Swerdlow A, Slater S, Burden A, Morris A, Waugh NR, et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia. 2003; 46(6): 760-5. [DOI:10.1007/s00125-003-1116-6]
8. Conrad P, Mackie T, Mehrotra A. Estimating the costs of medicalization. Social Science & Medicine. 2010; 70(12): 1943-7. [DOI:10.1016/j.socscimed.2010.02.019]
9. Association AD. The Cost of Diabetes 2019. Available from URL: http://www.diabetes.org/ advocacy/news-events/cost-of-diabetes.html.
10. Association AD. Economic costs of diabetes in the US in 2007. Diabetes Care. 2008; 31(3): 596-615. [DOI:10.2337/dc08-9017]
11. Govan L, Wu O, Briggs A, Colhoun H, McKnight J, Morris A, et al. Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia. 2011; 54(8): 2000-8. [DOI:10.1007/s00125-011-2176-7]
12. Cobas RA, Ferraz MB, Matheus ASdM, Tannus LRM, Negrato CA, Araujo LAd, et al. The cost of type 1 diabetes: a nationwide multicentre study in Brazil. Bulletin of the World Health Organization. 2013; 91: 434-40. [DOI:10.2471/BLT.12.110387]
13. Javanbakht M, Baradaran HR, Mashayekhi A, Haghdoost AA, Khamseh ME, Kharazmi E, et al. Cost-of-illness analysis of type 2 diabetes mellitus in Iran. PloS one. 2011; 6(10): e26864. [DOI:10.1371/journal.pone.0026864]
14. Esteghamati A, Khalilzadeh O, Anvari M, Meysamie A, Abbasi M, Forouzanfar M, et al. The economic costs of diabetes: a population-based study in Tehran, Iran. Diabetologia. 2009; 52(8): 1520-7. [DOI:10.1007/s00125-009-1398-4]
15. González JC, Walker JH, Einarson TR. Cost-of-illness study of type 2 diabetes mellitus in Colombia. Revista Panamericana de Salud Pública. 2009; 26: 55-63. [DOI:10.1590/S1020-49892009000700009]
16. diabetes. diabetes 2020. Available from URL: https://pezeshket.com/general-internal/%D8%AF%DB%8C%D8%A7%D8%A8%D8%AA-%D9%86%D9%88%D8%B9-1-f/
17. Administration FaD. Iranian Drug List 2019. Available from URL: http://irc.fda.gov.ir/NFI/ Search?Term=%D8%A2%D8%B3%D9%BE%D8%A7%D8%B1%D8%AA
18. Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nature Reviews Endocrinology. 2016; 12(10): 616. [DOI:10.1038/nrendo.2016.105]
19. Berhan Y, Waernbaum I, Lind T, Möllsten A, Dahlquist G, Group SCDS. Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes. 2011; 60(2): 577-81. [DOI:10.2337/db10-0813]
20. Hart W, Espinosa C, Rovira J. A simulation model of the cost of the incidence of IDDM in Spain. Diabetologia. 1997; 40(3): 311-8. [DOI:10.1007/s001250050680]
21. Shaw J, Tanamas S. Diabetes: the silent pandemic and its impact on Australia. Melbourne: Baker IDI Heart and Diabetes Institute. 2012.
22. Gray A, Fenn P, McGuire A. The cost of insulin‐dependent diabetes mellitus (IDDM) in England and Wales. Diabetic Medicine. 1995; 12(12): 1068-76. [DOI:10.1111/j.1464-5491.1995.tb00423.x]
23. Elrayah H, Eltom M, Bedri A, Belal A, Rosling H, Östenson C-G. Economic burden on families of childhood type 1 diabetes in urban Sudan. Diabetes Research and Clinical Practice. 2005; 70(2): 159-65. [DOI:10.1016/j.diabres.2005.03.034]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2017 All Rights Reserved | Evidence Based Health Policy, Management and Economics

Designed & Developed by : Yektaweb